Volume 11, Issue 2, Pages (February 2003)

Slides:



Advertisements
Similar presentations
Volume 127, Issue 4, Pages (November 2006)
Advertisements

3-Dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by.
Structure of the Rho Transcription Terminator
Volume 13, Issue 4, Pages (April 2008)
Crystal Structure of the Tandem Phosphatase Domains of RPTP LAR
Volume 11, Issue 3, Pages (March 2003)
Mark A Willis, Barney Bishop, Lynne Regan, Axel T Brunger  Structure 
Crystallographic Structure of SurA, a Molecular Chaperone that Facilitates Folding of Outer Membrane Porins  Eduard Bitto, David B. McKay  Structure 
Volume 27, Issue 4, Pages (October 2007)
Kristopher Josephson, Naomi J. Logsdon, Mark R. Walter  Immunity 
Structure of an LDLR-RAP Complex Reveals a General Mode for Ligand Recognition by Lipoprotein Receptors  Carl Fisher, Natalia Beglova, Stephen C. Blacklow 
Shiqing Li, Paul Kussie, Kathryn M. Ferguson  Structure 
Volume 124, Issue 1, Pages (January 2006)
Volume 21, Issue 7, Pages (July 2013)
Jessica P. Dawson, Zimei Bu, Mark A. Lemmon  Structure 
Volume 5, Issue 4, Pages (April 2004)
Volume 108, Issue 6, Pages (March 2002)
Volume 23, Issue 11, Pages (November 2015)
Yvonne Groemping, Karine Lapouge, Stephen J. Smerdon, Katrin Rittinger 
Volume 24, Issue 8, Pages (August 2016)
Mark Ultsch, Nathalie A Lokker, Paul J Godowski, Abraham M de Vos 
Volume 10, Issue 12, Pages (December 2002)
Volume 112, Issue 1, Pages (January 2003)
Volume 13, Issue 5, Pages (November 2000)
Volume 9, Issue 4, Pages (November 2014)
Crystal Structure at 2.8 Å of an FcRn/Heterodimeric Fc Complex
Volume 12, Issue 3, Pages (September 2003)
Volume 28, Issue 1, Pages (October 2007)
Crystal Structure of ARF1•Sec7 Complexed with Brefeldin A and Its Implications for the Guanine Nucleotide Exchange Mechanism  Elena Mossessova, Richard.
Volume 94, Issue 4, Pages (August 1998)
Solution and Crystal Structures of a Sugar Binding Site Mutant of Cyanovirin-N: No Evidence of Domain Swapping  Elena Matei, William Furey, Angela M.
Volume 11, Issue 5, Pages (May 2003)
Volume 101, Issue 7, Pages (June 2000)
Hong Ye, Young Chul Park, Mara Kreishman, Elliott Kieff, Hao Wu 
Structural Analysis of Ligand Stimulation of the Histidine Kinase NarX
Moosa Mohammadi, Joseph Schlessinger, Stevan R Hubbard  Cell 
Shaun K. Olsen, Christopher D. Lima  Molecular Cell 
Two structurally different RNA molecules are bound by the spliceosomal protein U1A using the same recognition strategy  Luca Jovine, Chris Oubridge, Johanna.
Daniel Peisach, Patricia Gee, Claudia Kent, Zhaohui Xu  Structure 
Qian Steven Xu, Rebecca B. Kucera, Richard J. Roberts, Hwai-Chen Guo 
Volume 95, Issue 7, Pages (December 1998)
Volume 7, Issue 4, Pages (April 2005)
Volume 91, Issue 5, Pages (November 1997)
Crystal Structure of the DegS Stress Sensor
Volume 12, Issue 7, Pages (July 2004)
Volume 91, Issue 7, Pages (December 1997)
Structural and Biophysical Studies of the Human IL-7/IL-7Rα Complex
Transformation of MutL by ATP Binding and Hydrolysis
David Jeruzalmi, Mike O'Donnell, John Kuriyan  Cell 
Volume 11, Issue 2, Pages (February 2003)
Structural Basis for FGF Receptor Dimerization and Activation
Volume 74, Issue 5, Pages (May 1998)
Mechanisms Contributing to T Cell Receptor Signaling and Assembly Revealed by the Solution Structure of an Ectodomain Fragment of the CD3ϵγ Heterodimer 
Volume 11, Issue 3, Pages (March 2003)
Structural Basis for Dimerization of ICAM-1 on the Cell Surface
The Structure of the β-Catenin/E-Cadherin Complex and the Molecular Basis of Diverse Ligand Recognition by β-Catenin  Andrew H. Huber, William I. Weis 
Volume 110, Issue 6, Pages (September 2002)
Volume 11, Issue 2, Pages (February 2003)
Neali Armstrong, Eric Gouaux  Neuron 
Crystal Structure of the Human Myeloid Cell Activating Receptor TREM-1
Diego Alvarado, Daryl E. Klein, Mark A. Lemmon  Cell 
Structure of the Staphylococcus aureus AgrA LytTR Domain Bound to DNA Reveals a Beta Fold with an Unusual Mode of Binding  David J. Sidote, Christopher.
Volume 91, Issue 5, Pages (November 1997)
Volume 24, Issue 6, Pages (June 2016)
Volume 19, Issue 8, Pages (August 2011)
Pingwei Li, Gerry McDermott, Roland K. Strong  Immunity 
Peter König, Rafael Giraldo, Lynda Chapman, Daniela Rhodes  Cell 
Kristopher Josephson, Naomi J. Logsdon, Mark R. Walter  Immunity 
A Molecular View of Anti-ErbB Monoclonal Antibody Therapy
Volume 95, Issue 2, Pages (October 1998)
Presentation transcript:

Volume 11, Issue 2, Pages 507-517 (February 2003) EGF Activates Its Receptor by Removing Interactions that Autoinhibit Ectodomain Dimerization  Kathryn M Ferguson, Mitchell B Berger, Jeannine M Mendrola, Hyun-Soo Cho, Daniel J Leahy, Mark A Lemmon  Molecular Cell  Volume 11, Issue 2, Pages 507-517 (February 2003) DOI: 10.1016/S1097-2765(03)00047-9

Figure 1 Structure of the Autoinhibited sEGFR Monomer (A) Ribbon representation of sEGFR, with domain I (L1) colored blue, domain II (S1) green, domain III (L2) yellow, and domain IV (S2) red. N and C termini are labeled. Disulfide bonds in domains II and IV that constitute C1 disulfide-bonded modules are black, while those in C2 modules are gray. Individual C1 and C2 modules are labeled in domain IV as described in the text. Disulfide bonds in domains I and III are colored yellow. The domain I-bound EGF molecule (see Figure 2) has been omitted for clarity. (B) Detail of the region boxed in (A), showing autoinhibitory intramolecular interactions between the second C1 module of domain II (C1IIb) and the C1IVc and C1IVd modules of domain IV. Parts of domains II and IV shown have green and red surfaces, respectively, with backbones represented by green and red worms. Interdomain hydrogen bonds are drawn as white dashed lines. Molecular Cell 2003 11, 507-517DOI: (10.1016/S1097-2765(03)00047-9)

Figure 2 Space-Filling Representation of sEGFR with Domain I-Bound EGF sEGFR is shown in CPK representation, with subdomains colored as in Figure 1. Bound EGF is magenta. EGF is intimately associated with domain I (blue) but does not come closer than 4 Å away from domain III. The side chain of Y14 (projecting from the left-hand side of EGF) is too distant from domain III to participate in hydrogen bonding. Molecular Cell 2003 11, 507-517DOI: (10.1016/S1097-2765(03)00047-9)

Figure 3 Binding of sEGFR to EGF Is Reduced at Low pH Binding of sEGFR (at 150 nM) to immobilized EGF was measured at different pH values using BIAcore as described in the Experimental Procedures. The midpoint of this titration is at approximately pH 7.3. Molecular Cell 2003 11, 507-517DOI: (10.1016/S1097-2765(03)00047-9)

Figure 4 Model for EGF-Promoted Domain Rearrangement in sEGFR, Leading to Dimerization The domain rearrangement promoted by bivalent binding of EGF to both domains I and III was approximated as described in the text and is depicted with ribbon models and cartoon forms. Modeled structures (B–D) are shown on a gray background. (A) sEGFR, in the same orientation and with the same coloring as in Figure 1A. Domain I-bound EGF is colored magenta. Key residues in EGF that must be docked onto domain III in the dimer (R41 and L47) are surrounded by an ellipse labeled “iii”. A hydrophobic pocket on domain III, into which L47 projects in the EGF•sEGFR dimer (Garrett et al., 2002; Ogiso et al., 2002), is circled and marked “i”. The side chain of D355 on domain III, which hydrogen bonds with R41 of EGF in the dimer, is also circled and marked “ii”. Domain I-bound EGF can be correctly docked on to domain III by 130° anticlockwise rotation of the domain I/II rigid body (plus EGF) about the axis marked by a filled black circle, plus a translation along this axis (into the page) of 20 Å. (B) This domain rearrangement allows EGF binding to both domains I and III of an extended sEGFR molecule in which the domain II dimerization loop is exposed (and faces out of the page in this view). We have not attempted to model the polypeptide in the region of the rotation axis. (C) The entire model for extended sEGFR has been rotated 90° about the vertical axis marked (from its orientation in [B]), to provide a view in which exposure of the domain II dimerization arm (C1IIb loop) and domain IV C1IVd loop (marked with an asterisk) can be appreciated. (D) The extended sEGFR molecule, with EGF bound to domains I and III, dimerizes through domain II-mediated interactions, with possible additional contributions from domain IV (Berezov et al., 2002; Schlessinger, 2002). The dimer model shown uses the coordinates of the EGF•sEGFR dimer from Ogiso et al. (2002), to which we have added domain IV (by maintaining the domains III/IV relationship seen in [A]). While domains I, III, and IV are unaltered in structure and orientation in going from (C) to (D), the conformation of domain II is altered significantly (see text). For clarity, domain II on the right-hand sEGFR molecule in the dimer is colored black. Molecular Cell 2003 11, 507-517DOI: (10.1016/S1097-2765(03)00047-9)

Figure 5 Mutations that Disrupt Intramolecular Domain II/IV Interactions Increase EGF Binding Affinity EGF binding to wild-type and mutated sEGFR was measured using surface plasmon resonance (BIAcore). As reported previously (Ferguson et al., 2000), wild-type sEGFR (black curve) binds to EGF with a KD of 132 ± 9.9 nM. Mutation of K585 to alanine increased binding affinity to give a KD of 54.3 ± 8.3 nM (blue curve), mutation of both D563 and H566 to alanine gave a KD of 58.8 ± 5.5nM (green curve), and a triple D563A/H566A/K585A mutant binds with KD = 50.7 ± 6.3 nM (red curve). Mean results from at least three independent experiments are plotted, with errors shown as standard deviations. Molecular Cell 2003 11, 507-517DOI: (10.1016/S1097-2765(03)00047-9)

Figure 6 Different Domain Orientations in Autoinhibited Structures of sEGFR and sErbB3 The structures of autoinhibited sEGFR and sErbB3 (Cho and Leahy, 2002) were overlaid by superimposition of domains III and IV. (A) The sEGFR/sErbB3 overlay is shown in the orientation used for sEGFR in Figure 1A. sEGFR is gray; sErbB3 is magenta. (B) The same sEGFR/sErbB3 overlay is shown in an orthogonal view to illustrate the different orientation of the domain I/II fragment in the two structures. The difference is approximated by a 60° rotation about the axis marked with a black circle. Molecular Cell 2003 11, 507-517DOI: (10.1016/S1097-2765(03)00047-9)

Figure 7 Crystallographic Dimer of Inactive sEGFR (A) Stereo view of the crystallographic dimer. One protomer (shaded gray, with domain IV black) is behind, while the other (with domains colored as in Figure 1A) is in front. EGF is colored magenta in both protomers. N and C termini and individual domains are all labeled. Three domain II side chains are shown: Y246, which is involved in the intramolecular domain II/IV interaction, plus N247 and D254, which make hydrogen bonds to domain IV of the adjacent molecule in this dimer (involving the carbonyl oxygen of N528 and amide nitrogen of V526, respectively, shown in ball and stick representation). If this dimer exists in vivo, the plane of the membrane would pass under the structure, perpendicular to the page. (B) The dimer shown in (A) has been rotated by 90° about the horizontal axis shown to give a view facing up from the presumed membrane plane. The C termini project out of the page. Regions of intermolecular interaction between N247 and D256 on domain II and the backbone of domain IV are circled. Molecular Cell 2003 11, 507-517DOI: (10.1016/S1097-2765(03)00047-9)